Financial results - TRINITY PHARMA SRL

Financial Summary - Trinity Pharma Srl
Unique identification code: 30707810
Registration number: J40/10998/2012
Nace: 4646
Sales - Ron
19.966
Net Profit - Ron
-21.727
Employee
1
The most important financial indicators for the company Trinity Pharma Srl - Unique Identification Number 30707810: sales in 2023 was 19.966 euro, registering a net profit of -21.727 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Trinity Pharma Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 55.669 39.217 32.001 50.909 27.016 35.748 180.059 78.470 80.851 19.966
Total Income - EUR 57.102 40.616 34.356 52.387 27.264 36.113 181.739 81.231 88.107 33.349
Total Expenses - EUR 40.664 51.651 31.919 38.172 44.620 36.914 157.554 72.231 89.910 54.791
Gross Profit/Loss - EUR 16.438 -11.036 2.437 14.215 -17.356 -801 24.185 9.000 -1.803 -21.442
Net Profit/Loss - EUR 15.416 -11.036 1.750 13.685 -17.708 -1.159 22.383 8.192 -2.612 -21.727
Employees 2 2 1 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -75.2%, from 80.851 euro in the year 2022, to 19.966 euro in 2023.

Check the financial reports for the company - Trinity Pharma Srl

Rating financiar

Financial Rating -
Trinity Pharma Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Trinity Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Trinity Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Trinity Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Trinity Pharma Srl - CUI 30707810

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 8.560 6.093 0 0 0 0 0 0 0 0
Current Assets 55.232 32.052 26.532 44.602 38.851 25.756 83.790 141.085 168.474 375.811
Inventories 13.147 8.775 123 121 0 0 0 0 33.361 304.302
Receivables 3.475 17.922 22.924 39.941 38.725 15.184 69.885 140.813 86.361 67.397
Cash 38.610 5.354 3.485 4.540 126 10.572 13.905 271 48.753 4.113
Shareholders Funds 2.893 -8.119 -6.286 7.505 -10.340 -11.299 10.591 18.549 15.995 -5.780
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 60.930 46.712 33.250 37.513 49.600 37.456 73.328 122.577 152.480 381.635
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 375.811 euro in 2023 which includes Inventories of 304.302 euro, Receivables of 67.397 euro and cash availability of 4.113 euro.
The company's Equity was valued at -5.780 euro, while total Liabilities amounted to 381.635 euro. Equity decreased by -21.727 euro, from 15.995 euro in 2022, to -5.780 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Trinity Pharma Srl

Comments - Trinity Pharma Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.